These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6865852)

  • 21. Branched chain amino acids in the treatment of hepatic encephalopathy.
    Rossi-Fanelli F
    Adv Exp Med Biol; 1990; 272():227-33. PubMed ID: 2103689
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatic encephalopathy: a clinical analysis of 107 cases].
    Wang XG
    Zhonghua Wai Ke Za Zhi; 1988 Jul; 26(7):396-9, 444-5. PubMed ID: 3229250
    [No Abstract]   [Full Text] [Related]  

  • 23. [Valine and branched-chain amino acids in the treatment of hepatic encephalopathy].
    Grüngreiff K; Kleine FD; Musil HE; Diete U; Franke D; Klauck S; Päge I; Kleine S; Lössner B; Pfeiffer KP
    Z Gastroenterol; 1993 Apr; 31(4):235-41. PubMed ID: 8493803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
    Rossi Fanelli F; Cangiano C; Capocaccia L; Cascino A; Ceci F; Muscaritoli M; Giunchi G
    Gut; 1986 Nov; 27 Suppl 1(Suppl 1):111-5. PubMed ID: 3539709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual evoked potential recordings in hepatic encephalopathy and their variations during branched chain amino-acid treatment.
    Bombardieri G; Gigli GL; Bernardi L; Ferri R; Grassi C; Milani A
    Hepatogastroenterology; 1985 Feb; 32(1):3-7. PubMed ID: 3921445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants.
    Eriksson LS; Conn HO
    Hepatology; 1989 Aug; 10(2):228-46. PubMed ID: 2663696
    [No Abstract]   [Full Text] [Related]  

  • 27. Disease-specific amino acid infusion (F080) in hepatic encephalopathy.
    Cerra FB
    JPEN J Parenter Enteral Nutr; 1987; 11(1):107-8. PubMed ID: 3820517
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids--a case report.
    Fukuda K; Yao H; Murai K; Ibayashi S; Fujishima M
    Fukuoka Igaku Zasshi; 1999 Dec; 90(12):464-9. PubMed ID: 10655667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Awakening effects of branched-chain amino acid infusion in hepatic coma].
    Kaito I; Suzuki K; Kato A; Sato S
    Nihon Rinsho; 1982; 40(4):811-6. PubMed ID: 7098051
    [No Abstract]   [Full Text] [Related]  

  • 31. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.
    Eriksson LS; Persson A; Wahren J
    Gut; 1982 Oct; 23(10):801-6. PubMed ID: 6749604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional pharmacology.
    DiPalma JR
    Am Fam Physician; 1985 Aug; 32(2):171-3. PubMed ID: 2992258
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral BCAA in the treatment of chronic hepatic encephalopathy.
    Marchesini G; Bianchi G; Zoli M
    J Hepatol; 1991 Mar; 12(2):267. PubMed ID: 1888373
    [No Abstract]   [Full Text] [Related]  

  • 34. [Liver, protein metabolism and branched-chain amino acids].
    Bernardi R
    Clin Ter; 1981 Dec; 99(6):653-75. PubMed ID: 7037278
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study.
    Plauth M; Egberts EH; Hamster W; Török M; Müller PH; Brand O; Fürst P; Dölle W
    J Hepatol; 1993 Mar; 17(3):308-14. PubMed ID: 8315258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Branched-chain amino acids in chronic liver failure: good friends or hated enemies?
    Rossi Fanelli F; Cangiano C
    Nutrition; 1990; 6(5):414-5. PubMed ID: 2134568
    [No Abstract]   [Full Text] [Related]  

  • 37. [Portal-systemic shunt with cerebellar ataxia as the initial neurological manifestation which was dramatically improved by an intravenous administration of branched amino acid].
    Deguchi K; Manabe Y; Takahashi K; Ota T; Takamatsu K; Ida K; Ota K; Abe K
    No To Shinkei; 2002 Jan; 54(1):35-40. PubMed ID: 11868349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of hepatic encephalopathy].
    Egberts EH
    Leber Magen Darm; 1987 Aug; 17(4):244, 247-62, 265-73. PubMed ID: 3312884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of nutrition in hepatic encephalopathy.
    Schulz GJ; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):275-80. PubMed ID: 18403924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfur-containing amino acids in experimental hepatic coma in the dog and the monkey.
    Smith AR; Rossi-Fanelli F; Freund H; Fischer JE
    Surgery; 1979 Jun; 85(6):677-83. PubMed ID: 109939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.